Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function

Vanna Zanagnolo, Arunasalam M. Dharmarajan, John Hesla, Edward E. Wallach

Research output: Contribution to journalArticle

Abstract

This study was undertaken to elucidate the effects of a GnRH analog (GnRH-a) on rabbit ovulation, oocyte maturation, and steroidogenesis, and to verify whether treatment with a GnRH-a interferes with ovarian response to exogenous gonadotropin (hCG), both in vivo and in vitro. Three approaches were used. In the first, adult New Zealand White (NZW) rabbits were divided into two groups. Both received PMSG and hCG administered 72 h after PMSG. In the test group a GnRH-a, leuprolide acetate (LA; 20 μg/kg) was administered sc every 24 h. Treated rabbits showed a significant decrease in ovulatory efficiency (control = 88%; treated = 72%), and an increase in degeneration rate of preimplantation embryos (control = 30% vs. treated = 40%). For the second approach, in vitro perfusion experiments were designed to compare the direct effects of LA (10.000 ng/ml) and hCG (50 IU) on ovarian function and to verify whether the presence of a GnRH-a in the perfusate modifies the actions of hCG. LA reduced the ovulatory efficiency of hCG-treated ovaries perfused in vitro (hCG-treated =87%; hCG-treated LA-perfused = 70%), reduced the potential for preimplantation development (morula stage: hCG-treated = 53%; hCG-treated LA-perfused = 31%; LA-perfused = 12%), and increased the degeneration rate of early embryos (21%, 48%, and 56% respectively). In the third approach, the direct effect of LA (Group I: control, Group II:1.000 ng/ml, and Group III:10.000 ng/ml) on the in vitro maturation of denuded rabbit oocytes was evaluated. LA induced meiotic maturation, hut increased oocyte degeneration rate. The potential for preimplantation development was reduced (Morula stage: control = 16%, Group II = 8%, and Group III = 6%), and degeneration trite was increased (38%, 65%, 63% respectively). This study suggests that pharmacological doses of LA may exert a negative effect on oocyte function by direct action on the oocyte, indirectly via alteration of the intrafollicular environment and/or through interference with gonadotropin-induced biological effects within the ovary.

Original languageEnglish
Pages (from-to)5400-5406
Number of pages7
JournalEndocrinology
Volume137
Issue number12
DOIs
Publication statusPublished - 1996

Fingerprint

Gonadotropin-Releasing Hormone
Oocytes
Rabbits
Morula
Gonadotropins
Ovary
Leuprolide
Control Groups
Blastocyst
Ovulation
Embryonic Structures
Perfusion
Pharmacology
In Vitro Techniques

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function. / Zanagnolo, Vanna; Dharmarajan, Arunasalam M.; Hesla, John; Wallach, Edward E.

In: Endocrinology, Vol. 137, No. 12, 1996, p. 5400-5406.

Research output: Contribution to journalArticle

Zanagnolo, Vanna ; Dharmarajan, Arunasalam M. ; Hesla, John ; Wallach, Edward E. / Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function. In: Endocrinology. 1996 ; Vol. 137, No. 12. pp. 5400-5406.
@article{4e89d5196149444d8a66030d846815f6,
title = "Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function",
abstract = "This study was undertaken to elucidate the effects of a GnRH analog (GnRH-a) on rabbit ovulation, oocyte maturation, and steroidogenesis, and to verify whether treatment with a GnRH-a interferes with ovarian response to exogenous gonadotropin (hCG), both in vivo and in vitro. Three approaches were used. In the first, adult New Zealand White (NZW) rabbits were divided into two groups. Both received PMSG and hCG administered 72 h after PMSG. In the test group a GnRH-a, leuprolide acetate (LA; 20 μg/kg) was administered sc every 24 h. Treated rabbits showed a significant decrease in ovulatory efficiency (control = 88{\%}; treated = 72{\%}), and an increase in degeneration rate of preimplantation embryos (control = 30{\%} vs. treated = 40{\%}). For the second approach, in vitro perfusion experiments were designed to compare the direct effects of LA (10.000 ng/ml) and hCG (50 IU) on ovarian function and to verify whether the presence of a GnRH-a in the perfusate modifies the actions of hCG. LA reduced the ovulatory efficiency of hCG-treated ovaries perfused in vitro (hCG-treated =87{\%}; hCG-treated LA-perfused = 70{\%}), reduced the potential for preimplantation development (morula stage: hCG-treated = 53{\%}; hCG-treated LA-perfused = 31{\%}; LA-perfused = 12{\%}), and increased the degeneration rate of early embryos (21{\%}, 48{\%}, and 56{\%} respectively). In the third approach, the direct effect of LA (Group I: control, Group II:1.000 ng/ml, and Group III:10.000 ng/ml) on the in vitro maturation of denuded rabbit oocytes was evaluated. LA induced meiotic maturation, hut increased oocyte degeneration rate. The potential for preimplantation development was reduced (Morula stage: control = 16{\%}, Group II = 8{\%}, and Group III = 6{\%}), and degeneration trite was increased (38{\%}, 65{\%}, 63{\%} respectively). This study suggests that pharmacological doses of LA may exert a negative effect on oocyte function by direct action on the oocyte, indirectly via alteration of the intrafollicular environment and/or through interference with gonadotropin-induced biological effects within the ovary.",
author = "Vanna Zanagnolo and Dharmarajan, {Arunasalam M.} and John Hesla and Wallach, {Edward E.}",
year = "1996",
doi = "10.1210/en.137.12.5400",
language = "English",
volume = "137",
pages = "5400--5406",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Effects of a gonadotropin-releasing hormone analog on rabbit ovarian function

AU - Zanagnolo, Vanna

AU - Dharmarajan, Arunasalam M.

AU - Hesla, John

AU - Wallach, Edward E.

PY - 1996

Y1 - 1996

N2 - This study was undertaken to elucidate the effects of a GnRH analog (GnRH-a) on rabbit ovulation, oocyte maturation, and steroidogenesis, and to verify whether treatment with a GnRH-a interferes with ovarian response to exogenous gonadotropin (hCG), both in vivo and in vitro. Three approaches were used. In the first, adult New Zealand White (NZW) rabbits were divided into two groups. Both received PMSG and hCG administered 72 h after PMSG. In the test group a GnRH-a, leuprolide acetate (LA; 20 μg/kg) was administered sc every 24 h. Treated rabbits showed a significant decrease in ovulatory efficiency (control = 88%; treated = 72%), and an increase in degeneration rate of preimplantation embryos (control = 30% vs. treated = 40%). For the second approach, in vitro perfusion experiments were designed to compare the direct effects of LA (10.000 ng/ml) and hCG (50 IU) on ovarian function and to verify whether the presence of a GnRH-a in the perfusate modifies the actions of hCG. LA reduced the ovulatory efficiency of hCG-treated ovaries perfused in vitro (hCG-treated =87%; hCG-treated LA-perfused = 70%), reduced the potential for preimplantation development (morula stage: hCG-treated = 53%; hCG-treated LA-perfused = 31%; LA-perfused = 12%), and increased the degeneration rate of early embryos (21%, 48%, and 56% respectively). In the third approach, the direct effect of LA (Group I: control, Group II:1.000 ng/ml, and Group III:10.000 ng/ml) on the in vitro maturation of denuded rabbit oocytes was evaluated. LA induced meiotic maturation, hut increased oocyte degeneration rate. The potential for preimplantation development was reduced (Morula stage: control = 16%, Group II = 8%, and Group III = 6%), and degeneration trite was increased (38%, 65%, 63% respectively). This study suggests that pharmacological doses of LA may exert a negative effect on oocyte function by direct action on the oocyte, indirectly via alteration of the intrafollicular environment and/or through interference with gonadotropin-induced biological effects within the ovary.

AB - This study was undertaken to elucidate the effects of a GnRH analog (GnRH-a) on rabbit ovulation, oocyte maturation, and steroidogenesis, and to verify whether treatment with a GnRH-a interferes with ovarian response to exogenous gonadotropin (hCG), both in vivo and in vitro. Three approaches were used. In the first, adult New Zealand White (NZW) rabbits were divided into two groups. Both received PMSG and hCG administered 72 h after PMSG. In the test group a GnRH-a, leuprolide acetate (LA; 20 μg/kg) was administered sc every 24 h. Treated rabbits showed a significant decrease in ovulatory efficiency (control = 88%; treated = 72%), and an increase in degeneration rate of preimplantation embryos (control = 30% vs. treated = 40%). For the second approach, in vitro perfusion experiments were designed to compare the direct effects of LA (10.000 ng/ml) and hCG (50 IU) on ovarian function and to verify whether the presence of a GnRH-a in the perfusate modifies the actions of hCG. LA reduced the ovulatory efficiency of hCG-treated ovaries perfused in vitro (hCG-treated =87%; hCG-treated LA-perfused = 70%), reduced the potential for preimplantation development (morula stage: hCG-treated = 53%; hCG-treated LA-perfused = 31%; LA-perfused = 12%), and increased the degeneration rate of early embryos (21%, 48%, and 56% respectively). In the third approach, the direct effect of LA (Group I: control, Group II:1.000 ng/ml, and Group III:10.000 ng/ml) on the in vitro maturation of denuded rabbit oocytes was evaluated. LA induced meiotic maturation, hut increased oocyte degeneration rate. The potential for preimplantation development was reduced (Morula stage: control = 16%, Group II = 8%, and Group III = 6%), and degeneration trite was increased (38%, 65%, 63% respectively). This study suggests that pharmacological doses of LA may exert a negative effect on oocyte function by direct action on the oocyte, indirectly via alteration of the intrafollicular environment and/or through interference with gonadotropin-induced biological effects within the ovary.

UR - http://www.scopus.com/inward/record.url?scp=0030459398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030459398&partnerID=8YFLogxK

U2 - 10.1210/en.137.12.5400

DO - 10.1210/en.137.12.5400

M3 - Article

C2 - 8940363

AN - SCOPUS:0030459398

VL - 137

SP - 5400

EP - 5406

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 12

ER -